NOVAVAX INC revenue breakdown overview

NOVAVAX INC revenue for the last year amounted to 891.25 M EUR, the most of which — 481.44 M EUR — came from its highest performing source at the moment, Innovative Vaccines, the year earlier bringing 1.45 B EUR. The greatest contribution to the revenue figure was made by Europe — last year it brought NOVAVAX INC 243.14 M EUR, and the year before that — 769.49 M EUR.